# The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)

Study · id `cardio:ct-nct05371366` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05371366](<https://clinicaltrials.gov/study/NCT05371366>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05371366

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 128 participants.

## Technical summary

Registry record NCT05371366. Randomized; no masking; primary purpose treatment. Start 2022-04-22 (actual); primary completion 2023-04-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 128 participants (planned count; ClinicalTrials.gov record NCT05371366, source copy `cardio:ctgov-nct05371366-2022-05-24`, retrieved 2026-10-26)
- Started: 2022-04-22 (actual) (ClinicalTrials.gov record NCT05371366, source copy `cardio:ctgov-nct05371366-2022-05-24`, retrieved 2026-10-26)
- Primary completion: 2023-04-22 (anticipated) (ClinicalTrials.gov record NCT05371366, source copy `cardio:ctgov-nct05371366-2022-05-24`, retrieved 2026-10-26)
- Completion: 2023-04-22 (anticipated) (ClinicalTrials.gov record NCT05371366, source copy `cardio:ctgov-nct05371366-2022-05-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05371366, source copy `cardio:ctgov-nct05371366-2022-05-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05371366-2022-05-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)
- Condition: Atrial Septal Defect
- Intervention (Device): ASD closure with the novel occluder (ReAces)
- Intervention (Device): ASD closure with normal occluder
- Lead sponsor: Shanghai Zhongshan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Adult congenital heart disease (`cardio:adult-congenital-heart-disease`)
- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Device endothelialization and morphology assessments at 1 year using computed tomography angiography: comparison of traditional with novel puncturable atrial septal defect occluders (`cardio:pubmed-39734195`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of a Novel Occluder Versus Traditional Occluder in Atrial Septal Defect: A Randomized Trial (`cardio:pubmed-42757893`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c6feea3bac7084949875adb9bccbd7a35611c26d13f34e423980e013949eb45e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
